XOMA Royalty Corporation (LON:0M26)

Market Cap	211.19M -15.8%
Revenue (ttm)	35.04M +118.0%
Net Income	7.33M
EPS	0.61
Shares Out	n/a
PE Ratio	28.80
Forward PE	19.10
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15
Average Volume	230
Open	23.09
Previous Close	22.67
Day's Range	22.57 - 23.50
52-Week Range	18.78 - 39.85
Beta	0.86
RSI	35.09
Earnings Date	Mar 9, 2026

About XOMA Royalty

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1981
• Employees: 13
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0M26

Financial Performance

In 2024, XOMA Royalty's revenue was $28.49 million, an increase of 498.72% compared to the previous year's $4.76 million. Losses were -$19.29 million, -58.33% less than in 2023.

Financial numbers in USD